Skip to main content

Table 5 Cardiovascular and diabetic drug therapy from scan to 1 year post scan

From: Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study

 Baseline1 year post scanp
Anti-hypertensives
 Beta-blockers11 (17%)17 (27%)0.014*
 ACE inhibitor29 (46%)33 (52%)0.10
 Calcium channel blockers41 (65%)44 (69%)0.18
 Alpha-blockers5 (8%)7 (11%)0.32
 Diuretics5 (8%)8 (13%)0.08
 ARB12 (19%)13 (21%)0.32
Lipid-modifying agents
 Statin39 (62%)48 (76%)0.0067*
 Fibrates1 (2%)1 (2%)1
Anti-hyperglycaemic agents
 Acarbose1 (2%)1 (2%)1
 Sulfonylureas23 (37%)23 (37%)1
 SGLT-2 inhibitor11 (17%)16 (25%)0.025*
 Metformin57 (90%)59 (94%)0.16
 DDP-4 inhibitor26 (41%)27 (43%)0.71
 Insulin19 (30%)19 (30%)1
 Pioglitazone14 (22%)19 (30%)0.025*
Anti-platelet agents
 Clopidogrel4 (6%)12 (19%)0.0047*
 Aspirin15 (24%)27 (43%)0.0013*
  1. ACE angiotension converting enzyme, ARB angiotensin receptor blocker, SGLT-2 sodium-glucose co-transport 2 inhibitor, DDP-4 dipeptidyl peptidase-4
  2. * p < 0.05